Skip to main content
CriticalFDAfda-F-0845-2013UNDECLARED ALLERGEN

Newman's Own Lite Honey Mustard Dressing, 16 FL.OZ (473 mL)

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
6,922
Recall Date
November 23, 2012
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0845-2013.

Newman's Own Lite Honey Mustard Dressing was labeled with an incorrect back label that did not list the allergen milk.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0845-2013.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Newman's Own Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0845-2013.

Newman'S Own Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Newman's Own Inc. Recall FAQ

Newman's Own Inc. is the subject of a food safety report: Newman's Own Lite Honey Mustard Dressing, 16 FL.OZ (473 mL). The notice was published on November 23, 2012 by the U.S. Food and Drug Administration (FDA). Approximately 6,922 units are potentially affected.